Mannkind Corp
Mannkind Corp (MNKD) Covered Calls
As of September 25, 2026, MNKD has 11 covered call opportunities in the coming three months. Return ranges from 7.9 to 129.5% until expiration. Annualized return ranges from 31.2 to 271.0%. The nearest expiration is October 16, 2026. Maximum potential profit is $426.
Read more
Running MNKD covered calls helps you generate consistent income from Mannkind Corp's shares you already own, turning a long stock position into a yield-producing asset. A covered call on Mannkind Corp involves holding the underlying stock and selling a call option against it, collecting premium in exchange for capping upside at the strike price. Use our scanner to find the best MNKD covered calls in real time and filter for the strikes, expiries, and premiums that fit your strategy.
A covered call is one of the most widely used options strategies because it pairs limited risk with a clear income profile: if MNKD stays below the strike at expiration, you keep the premium and the shares; if it rises above, you deliver the stock at the strike and still pocket the premium. Selling MNKD covered calls works best when implied volatility is elevated, since richer premiums improve the risk-reward. Key inputs to evaluate include strike selection relative to delta, days to expiration, annualized return, and the probability of assignment — all of which determine whether a given Mannkind Corp covered call is worth writing.
MannKind Corporation, a biopharmaceutical company, focuses on the development and commercialization of inhaled therapeutic products for endocrine and orphan lung diseases in the United States. It offers Afrezza, an inhaled insulin used to improve glycemic control in adults with diabetes. It also promotes Thyquidity to adult and pediatric endocrinologists, and other healthcare providers for the treatment of hypothyroidism. The company has a license and collaboration agreement with United Therapeutics Corporation. It also has an agreement with NRx Pharmaceuticals to develop a dry powder formulation of ZYESAMI (aviptadil), a synthetic form of human vasoactive intestinal peptide to help protect cells against inflammatory conditions.
MannKind Corporation was incorporated in 1991 and is headquartered in Westlake Village, California.
Income-focused investors, long-term MNKD holders, and systematic premium sellers all face the same challenge: finding the covered call strike and expiry that balances yield against the risk of being called away. Our scanner ranks covered calls by annualized return, downside protection, and probability of profit, so selling MNKD covered calls becomes a measured decision instead of a guess. Stop eyeballing the chain — let the best Mannkind Corp covered calls come to you, already filtered for the metrics that matter.
Stock Statistics
- IndustryBiotechnology
- SectorHealthcare
- IV percentile38.10% Neutral
- Market cap (M$)1,074
- 52 weeks high-48.69%
- 52 weeks low49.78%
- Analyst recommendationStrong Buy
1.25 - Target price$7.97
138.62% above the current stock price - Dividend—
- Payout ratio0.00%
- Earnings date2026-11-04
- P/E—
- Future P/E—
- EPS (ttm)-0.14
- EPS growth next 5 years43.79%
As of September 25, 2026
| 2027-01-15 | 113 | 6.00 | 82.37 | 0.05 | 0.40 | 276.00 | 83.89 | 270.97 | -1.52 | +0.25 | 157 | 0.35 |
| 2027-01-15 | 113 | 5.00 | 51.98 | 0.10 | 0.30 | 181.00 | 55.02 | 177.70 | -3.04 | +0.26 | 4,223 | 0.20 |
| 2026-11-20 | 57 | 4.00 | 21.58 | 0.05 | 0.20 | 76.00 | 23.10 | 147.92 | -1.52 | +0.27 | 270 | 0.15 |
| 2026-10-16 | 22 | 3.50 | 6.38 | 0.05 | 0.50 | 26.00 | 7.90 | 131.11 | -1.52 | +0.47 | 1 | 0.45 |
| 2027-01-15 | 113 | 4.00 | 21.58 | 0.30 | 0.60 | 101.00 | 30.70 | 99.16 | -9.12 | +0.46 | 1,877 | 0.30 |
| 2027-05-21 | 239 | 5.00 | 51.98 | 0.30 | 0.50 | 201.00 | 61.09 | 93.30 | -9.12 | +0.38 | 7 | 0.20 |
| 2028-01-21 | 484 | 7.00 | 112.77 | 0.25 | 0.70 | 396.00 | 120.36 | 90.77 | -7.60 | +0.36 | 1,093 | 0.45 |
| 2029-01-19 | 848 | 7.00 | 112.77 | 0.55 | 0.85 | 426.00 | 129.48 | 55.73 | -16.72 | +0.45 | 9 | 0.30 |
| 2027-05-21 | 239 | 4.00 | 21.58 | 0.25 | 0.90 | 96.00 | 29.18 | 44.56 | -7.60 | +0.51 | 10 | 0.65 |
| 2028-01-21 | 484 | 5.00 | 51.98 | 0.05 | 0.95 | 176.00 | 53.50 | 40.34 | -1.52 | +0.43 | 955 | 0.90 |
As of September 25, 2026
Sell covered calls with the data behind you
Find the best MNKD covered call setups ranked by annualized return, filter by premium, delta, and days to expiration, and act on the opportunity in seconds.
Start your 14-day free trial→